GLYDO 2% JELLY SYRINGE

What it is

GLYDO 2% JELLY SYRINGE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as lidocaine hydrochloride, under the trade name “glydo”.

FDA gives its dosage form as jelly and its route as topical.

The labeler, the company named on the label, is Sagent Pharmaceuticals.

FDA lists it under 2 Established Pharmacologic Classes: Amide Local Anesthetic and Antiarrhythmic.

The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $0.52 – $0.90 for 1 mL, depending on the NDC ($0.51624 to $0.89771 per ML), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

What NADAC measures · NADAC explanation codes

All 2 NDCs

• 25021-0673-76 · Sagent Pharmaceuticals · $0.89771 per ML · eff. 2026-09-23 filed
• 25021-0673-77 · Sagent Pharmaceuticals · $0.51624 per ML · eff. 2026-09-23 filed

Other strengths, forms and brands

19 other products in the NADAC file share the FDA nonproprietary name lidocaine hydrochloride with GLYDO 2% JELLY SYRINGE.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. between 2026-07-22 and 2026-10-07 (5 dates) · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 2 NDCs’ NADAC prices is $0.51624 per ML filed.

Of the 21 other products in FDA’s Amide Local Anesthetic class priced per ML, 3 have a higher middle NADAC price and 18 a lower one. The one in the middle is LIDOCAINE HCL 1% 100 MG/10 ML, at $0.13782 per ML filed (eff. 2026-09-23).

Of the 21 other products in FDA’s Antiarrhythmic class priced per ML, 5 have a higher middle NADAC price and 16 a lower one. The one in the middle is LIDOCAINE HCL 4% SOLUTION, at $0.22203 per ML filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

Medicare Part D paid $0.61 for 1 mL, at an average of $0.61103 per ML in 2024 (2024-01-01 to 2024-12-31) for “Glydo” and “Lidocaine HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 8,472 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 1 mL? Is it lower than what I would pay through my insurance?
• Which NDC (the 11-digit number on the package) is this? Pharmacies pay $0.51624 to $0.89771 per ML for this product, depending on the NDC.
• How much is in the package I am getting? This page uses 1 mL; your package may hold a different amount.
• If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.